HLA-A.md
... ...
@@ -26,15 +26,15 @@ timeline
26 26
27 27
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
28 28
29
-|Entity |Samples/Cohort |Incidence estimate (95% CI) |
30
-|:------|:-------------------|:---------------------------|
31
-|DLBCL |GAMBL without Reddy |0.0985 [0.0808,0.1163] |
32
-|DLBCL |GAMBL with Reddy |0.0112 [0.0062,0.0162] |
33
-|DLBCL |BC |0.0987 [0.0595,0.1378] |
34
-|DLBCL |Dana-Farber |0.0924 [0.0598,0.125] |
35
-|DLBCL |NCI |0.1106 [0.0823,0.139] |
36
-|DLBCL |Reddy |0.0037 [0,0.0089] |
37
-|DLBCL |DLBCL_ICGC |0.0706 [0.0161,0.125] |
29
+|Entity |Samples/Cohort |Incidence estimate (95% CI) |
30
+|:------|:-----------------------------------------|:---------------------------|
31
+|DLBCL |GAMBL without Reddy |0.1975 [0.174,0.221] |
32
+|DLBCL |GAMBL with Reddy |0.1914 [0.1724,0.2105] |
33
+|DLBCL |BC |0.1614 [0.1131,0.2097] |
34
+|DLBCL |Dana-Farber |0.1881 [0.1441,0.2321] |
35
+|DLBCL |NCI |0.2638 [0.224,0.3037] |
36
+|DLBCL |Reddy[@reddyGeneticFunctionalDrivers2017] |0.1798 [0.1472,0.2123] |
37
+|DLBCL |DLBCL_ICGC |0.1059 [0.0405,0.1713] |
38 38
39 39
## Mutation pattern and selective pressure estimates
40 40